Ryan Smith, MD
Ophthalmology · Lexington, KYNPI 1376980318
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.6%), consulting fees and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Glaukos Corporation at 33.5% of the total. 2025 is the largest year on record at $4,531, 8.4 times the $538 reported in 2019. Among ophthalmology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 182 payments — averaging $68.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$4K
- Alcon$2K
- Ivantis, Inc$2K
- AbbVie$925
- Johnson & Johnson Surgical Vision, Inc.$826
- Novartis$564
- plus $1K from 18 others
What the payments were for
- Consulting fees$5,37543%
- Food & beverage$6,93456%
- Education$1491%
- Gifts$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 11 | $4,182 |
| Alcon | 57 | $2,414 |
| Ivantis, Inc | 4 | $2,222 |
| AbbVie(2 entities) | 34 | $925 |
| Johnson & Johnson Surgical Vision, Inc. | 13 | $826 |
| Novartis | 17 | $564 |
| Bausch & Lomb Americas Inc. | 11 | $212 |
| Aerie Pharmaceuticals, Inc. | 9 | $160 |
| Ellexiscience | 1 | $144 |
| Rxsight Inc | 2 | $131 |
| Regeneron Healthcare Solutions, Inc. | 1 | $111 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $108 |
| Beaver-visitec International, Inc. | 2 | $92 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $79 |
| Kedrion Biopharma, Inc. | 1 | $66 |
| Ocular Therapeutix, Inc. | 3 | $57 |
| Alcon Research LLC | 1 | $38 |
| Tarsus Pharmaceuticals, Inc. | 1 | $30 |
| Kala Pharmaceuticals, Inc. | 2 | $28 |
| Amgen | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Harrow Eye, LLC | 1 | $14 |
| Lensar, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Hydrus Microstent$2,529
- Centurion$270
- XIIDRA$250
- iDoseTR$171
- LenSx$150
- Clareon$148
- CATALYS SYSTEM$135
- iStent inject W$125
- IACCESS$125
- Tecnis Simplicity$124
- WaveLight EX500 Excimer Laser$119
- EYLEA$111
- AcrySof IQ VIVITY IOL$107
- RXSIGHT CONTACT LENS$105
- RXSIGHT INJECTOR CARTRIDGE$105
- RXSIGHT INJECTOR HANDPIECE$105
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$105
- LIGHT ADJUSTABLE LENS (LAL)$105
- Tecnis IOL$102
- iDose$100
How this compares
$12,478 in reported general payments places this provider in the 95th percentile of 216 ophthalmology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 340 | $137,420 |
| RocklatanNetarsudil Mesylat/Latanoprost | 104 | $53,183 |
| XiidraLifitegrast | 50 | $50,578 |
| RhopressaNetarsudil Mesylate | 100 | $36,464 |
| RestasisCyclosporine | 28 | $26,876 |
| CombiganBrimonidine Tartrate/Timolol | 65 | $25,897 |
| VyzultaLatanoprostene Bunod | 25 | $13,900 |
| Travoprost | 106 | $13,467 |
| Prednisolone Acetate | 281 | $10,921 |
| Latanoprost | 857 | $8,269 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 424 | $6,486 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 21 | $6,267 |
| Alphagan PBrimonidine Tartrate | 21 | $5,580 |
| Timolol Maleate | 341 | $5,334 |
| Pilocarpine Hcl | 70 | $4,576 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Restasis, Combigan, Alphagan P | $925 | $195,772454 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $160 | $89,647204 claims |
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta | $212 | $64,47775 claims |
| AlconSimbrinza | $2,414 | $6,26721 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 216 ophthalmology providers in Kentucky.
Other ophthalmology in Lexington
- Gary WortzLexington$159K
- Bruce KofflerLexington$49K
- Asim PirachaLexington$17K
- Angelia ThompsonLexington$11K
- James HuffmanLexington$10K
- Shivani ReddyLexington$8K
- Paras VoraLexington$4K
- Michael TannerLexington$4K
- Edward HollandEdgewood$678K
- Jeremy ClarkLouisville$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.